In SLE, a disease in which CD8+ cells play a relatively minor role in pathogenesis, reduced CD161 expression on CD8+ T cells and NKT cells was noted in patients with advanced disease (67). This evidence concerns the gene KLRB1 and systemic lupus erythematosus.